Follow Us All RSS About Us

Most popular: AAPL AMD BJCT BMSN CHK CPYE DIS F FMD FTWR GLD KERX

DVAX (Dynavax Technologies)

remove frame

Back to Search

Yahoo! Finance

More buys AH

SQNM soaring

Chart

must read!!!!!!!!

Re: Check DVAX comment on GROW

Novartis to Acquire MAJORITY HTDS.PK H1N1 Vaccine Partner for US$125 Million

ADFN InvestorsHub

Dynavax Completes Enrollment of First Cohort of Patients

Brilliant financial data...

Dynavax to Acquire Symphony Dynamo, Inc., Including $20

The $2000 Swine Flu Drug

Dynavax's HEPLISAV Shows Increased Protection Rate for Chronic

Raging Bull

DVAX--meat of the deal today plus plus--

DVAX this is $17m for DVAX from NIH--

DVAX and Astra Zeneca this am--

DVAX and Glaxo Smith Kline--$800m deal-

I think it is a good buy right now!

Google Finance

BEST TRADING ALERTS - MAKES 300% WEEKLY RETURN HIGHLY RECOMMENDED

TURNED $1,000 INTO OVER $2 MILLION IN JUST A FEW MONTHS.. TRY IT

DARA SET TO SKY ROCKRT BY THURSDAY

EXCELLENT TRADING ALERTS - TURNED $1000 INTO 2 MILLION !!! HIGHLY RECOMMENDED #!!

Take a look at CSLI

The Motley Fool

Dynavax Appoints New Board Member

DVAX

Re: Tolamba trials

Tolamba trials

Greetings, Fool!

TheLion

Like some indicator movement-- wud esp love to see an Aroon crossover and the...

looking for a bounce here eom

adding back DVAX here $1.30 for bounce back eom

Nice buying activity going on last hour. eom

Nice call on DVAX Magician eom

All RSS

About BoardCentral | Contact | Advertise

© 1999-2008 BoardCentral^TM Inc. All Rights Reserved. Privacy statement and Disclaimer

Privacy statement and Terms of Use. Questions, comments, suggestions or disputes – please contact us. All copyrights, trademarks and other intellectual property rights referred to on these pages belong to their respective owners. By using this site you are agreeing to our terms of use, and agree not to redistribute the information found therein. All information provided on this site is "as is" and provided for informational and entertainment purposes only, not intended for trading purposes and should not be considered as investment advice.